Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos(University of Basel), Amit Bar‐Or(Montreal Neurological Institute and Hospital), Bruce Cree(University of California, San Francisco), Robert J. Fox(Cleveland Clinic), Gavin Giovannoni(Queen Mary University of London), Ralf Gold(St. Josef-Hospital), Patrick Vermersch(Inserm), Douglas L. Arnold(Montreal Neurological Institute and Hospital), Sophie Arnould(Novartis (Switzerland)), Tatiana Scherz(Novartis (Switzerland)), Christian Wolf(Sociétés Anonyme Belge de Constructions Aéronautiques (Belgium)), Erik Wallström(Novartis (Switzerland)), Frank Dahlke(Novartis (Switzerland)), Anat Achiron(NeuroRx Research (Canada)), Lutz Achtnichts(NeuroRx Research (Canada)), Kadriye Ağan(NeuroRx Research (Canada)), Gülşen Akman‐Demir(NeuroRx Research (Canada)), Alison Allen(NeuroRx Research (Canada)), Jack P. Antel(NeuroRx Research (Canada)), Alfredo Rodríguez Antigüedad(NeuroRx Research (Canada)), Michelle Apperson(NeuroRx Research (Canada)), Angela Applebee(NeuroRx Research (Canada)), Guillermo Izquierdo Ayuso(NeuroRx Research (Canada)), Masayuki Baba(NeuroRx Research (Canada)), Ovidiu Băjenaru(NeuroRx Research (Canada)), Rodica Balasa(NeuroRx Research (Canada)), Belgin Petek Balcı(NeuroRx Research (Canada)), Michael Barnett(NeuroRx Research (Canada)), Ann Bass(Queen Mary University of London), V. Becker(NeuroRx Research (Canada)), Mihaela Bejinariu(NeuroRx Research (Canada)), Florian Then Bergh(NeuroRx Research (Canada)), Arnfin Bergmann(NeuroRx Research (Canada)), Evanthia Bernitsas(NeuroRx Research (Canada)), Achim Berthele(NeuroRx Research (Canada)), Virender Bhan(NeuroRx Research (Canada)), Felix Bischof(NeuroRx Research (Canada)), Randall J. Bjork(NeuroRx Research (Canada)), Gregg Blevins(NeuroRx Research (Canada)), Matthias Boehringer(NeuroRx Research (Canada)), Thomas Boerner(NeuroRx Research (Canada)), Robert Bonek(Cleveland Clinic), James D. Bowen(NeuroRx Research (Canada)), Allen C. Bowling(NeuroRx Research (Canada)), Alexey Boyко(NeuroRx Research (Canada)), Cavit Boz(NeuroRx Research (Canada)), Vera Bracknies(NeuroRx Research (Canada)), Stefan Braune(NeuroRx Research (Canada)), Vincenzo Brescia Morra(NeuroRx Research (Canada)), Bruno Brochet(NeuroRx Research (Canada)), Waldemar Brola(NeuroRx Research (Canada)), Paul Brownstone(NeuroRx Research (Canada)), M Brozman(NeuroRx Research (Canada)), Donald Brunet(NeuroRx Research (Canada)), Ioan Buraga(NeuroRx Research (Canada)), Margaret Burnett(NeuroRx Research (Canada)), Mathias Buttmann(NeuroRx Research (Canada)), Helmut Butzkueven(NeuroRx Research (Canada)), Jonathan Cahill(NeuroRx Research (Canada)), Jonathan Calkwood(NeuroRx Research (Canada)), William Camu(NeuroRx Research (Canada)), Mark Cascione(NeuroRx Research (Canada)), G. Castelnovo(NeuroRx Research (Canada)), Diego Centonze(NeuroRx Research (Canada)), João Cerqueira(NeuroRx Research (Canada)), Andrew Chan(NeuroRx Research (Canada)), Andrea Cimprichová(NeuroRx Research (Canada)), Stanley Cohan(NeuroRx Research (Canada)), Giancarlo Comi(NeuroRx Research (Canada)), Jill Ker Conway(NeuroRx Research (Canada)), Joanna A. Cooper(NeuroRx Research (Canada)), John R. Corboy(NeuroRx Research (Canada)), Jorge Correale(NeuroRx Research (Canada)), Brian Costell(NeuroRx Research (Canada)), David A. Cottrell(NeuroRx Research (Canada)), Patricia K. Coyle(NeuroRx Research (Canada)), Matthew Craner(NeuroRx Research (Canada)), Liying Cui(NeuroRx Research (Canada)), Luı́s Cunha(NeuroRx Research (Canada)), Anna Członkowska(NeuroRx Research (Canada)), Ana Silva(NeuroRx Research (Canada)), Joao de(NeuroRx Research (Canada)), de Sèze(NeuroRx Research (Canada)), Marc Debouverie(NeuroRx Research (Canada)), Jan Debruyne(NeuroRx Research (Canada)), D. Decoo(NeuroRx Research (Canada)), G. Defer(NeuroRx Research (Canada)), Tobias Derfuß(NeuroRx Research (Canada)), Norma Deri(NeuroRx Research (Canada)), Bhupesh Dihenia(NeuroRx Research (Canada)), Péter Diószeghy(NeuroRx Research (Canada)), Vladimír Donáth(NeuroRx Research (Canada)), Bénédicte Dubois(NeuroRx Research (Canada)), Martin Duddy(NeuroRx Research (Canada)), Pierre Duquette(NeuroRx Research (Canada)), Gilles Edan(NeuroRx Research (Canada)), Hüsnü Efendi(NeuroRx Research (Canada)), Stanton B. Elias(NeuroRx Research (Canada)), Peter Emrich(NeuroRx Research (Canada)), Bonaventura Casanova Estruch(NeuroRx Research (Canada)), E. P. Evdoshenko(NeuroRx Research (Canada)), Juergen Faiss(NeuroRx Research (Canada)), Alexander S Fedyanin(NeuroRx Research (Canada)), Wolfgang Feneberg(NeuroRx Research (Canada)), Jiske Fermont(NeuroRx Research (Canada)), Óscar Fernández Fernández(NeuroRx Research (Canada)), Francisco Coret Ferrer(NeuroRx Research (Canada)), Katharina Fink(NeuroRx Research (Canada)), Helen Ford(NeuroRx Research (Canada)), Corey Ford(NeuroRx Research (Canada)), Ada Francia(NeuroRx Research (Canada)), Mark Freedman(NeuroRx Research (Canada)), Benjamin Frishberg(NeuroRx Research (Canada)), Simonetta Galgani(NeuroRx Research (Canada)), George P Garmany(NeuroRx Research (Canada)), Klaus Gehring(NeuroRx Research (Canada)), Jeffrey Gitt(NeuroRx Research (Canada)), Claudio Gobbi(NeuroRx Research (Canada)), Lawrence Goldstick(NeuroRx Research (Canada)), Rafael Arroyo González(NeuroRx Research (Canada)), François Grand’Maison(NeuroRx Research (Canada)), Nikolaos Grigoriadis(NeuroRx Research (Canada)), Olga Grigorova(NeuroRx Research (Canada)), Luigi M.E. Grimaldi(NeuroRx Research (Canada)), Jeffrey B. Gross(NeuroRx Research (Canada)), Katrin Gross‐Paju(NeuroRx Research (Canada)), Mark Gudesblatt(NeuroRx Research (Canada)), Daniel Guillaume(NeuroRx Research (Canada)), Judith Haas(NeuroRx Research (Canada)), Viera Hančinová(NeuroRx Research (Canada)), Anca Hâncu(NeuroRx Research (Canada)), Orla Hardiman(NeuroRx Research (Canada)), A. Harmjanz(NeuroRx Research (Canada)), Fedor Heidenreich(NeuroRx Research (Canada)), G.J.D. Hengstman(NeuroRx Research (Canada)), Joseph Herbert(NeuroRx Research (Canada)), Mark Herring(NeuroRx Research (Canada)), Suzanne Hodgkinson(NeuroRx Research (Canada)), Olaf Hoffmann(NeuroRx Research (Canada)), Werner Hofmann(NeuroRx Research (Canada)), William Honeycutt(NeuroRx Research (Canada)), Le H. Hua(NeuroRx Research (Canada)), Dehui Huang(NeuroRx Research (Canada)), Yining Huang(NeuroRx Research (Canada)), DeRen Huang(NeuroRx Research (Canada)), Raymond Hupperts(NeuroRx Research (Canada)), Piroska Imre(NeuroRx Research (Canada)), Alan Keith Jacobs(NeuroRx Research (Canada)), Gábor Jakab(NeuroRx Research (Canada)), Elżbieta Jasińska(NeuroRx Research (Canada)), Kenichi Kaida(NeuroRx Research (Canada)), Jolanta Kalniņa(NeuroRx Research (Canada)), Ara Kaprelyan(NeuroRx Research (Canada)), Guntis Karelis(NeuroRx Research (Canada)), Dimitrios Karussis(NeuroRx Research (Canada)), Amos Katz(NeuroRx Research (Canada)), Ф. А. Хабиров(NeuroRx Research (Canada)), Bhupendra Khatri(NeuroRx Research (Canada)), Takashi Kimura(NeuroRx Research (Canada)), Ilya Kister(NeuroRx Research (Canada)), Rasa Kizlaitienė(NeuroRx Research (Canada)), Eleonóra Klímová(NeuroRx Research (Canada)), Juergen Koehler(NeuroRx Research (Canada)), Aparna Komatineni(NeuroRx Research (Canada)), A. Kornhuber(NeuroRx Research (Canada)), Krisztina Kovács(NeuroRx Research (Canada)), Ágnes Köves(NeuroRx Research (Canada)), Wojciech Kozubski(NeuroRx Research (Canada)), Georgi Krastev(NeuroRx Research (Canada)), Lauren Krupp(NeuroRx Research (Canada)), Egon Kurča(NeuroRx Research (Canada)), Christoph Lassek(NeuroRx Research (Canada)), Guy Laureys(NeuroRx Research (Canada)), Liesly Lee(NeuroRx Research (Canada)), Eckart Lensch(NeuroRx Research (Canada)), Fritz Leutmezer(NeuroRx Research (Canada)), Hongzeng Li(NeuroRx Research (Canada)), Ralf A. Linker(St. Josef-Hospital), Michael Linnebank(NeuroRx Research (Canada)), Petra Lišková(NeuroRx Research (Canada)), Cristina Llanera(NeuroRx Research (Canada)), Jiahong Lu(University of Basel), Andreas Lutterotti(NeuroRx Research (Canada)), Jan Lycke(NeuroRx Research (Canada)), Richard Macdonell(NeuroRx Research (Canada)), Maciej Maciejowski(NeuroRx Research (Canada)), Mathias Maeurer(NeuroRx Research (Canada)), Р. В. Магжанов(NeuroRx Research (Canada)), Eva-Maria Maida(NeuroRx Research (Canada)), Lina Malcienė(NeuroRx Research (Canada)), Yang Mao‐Draayer(NeuroRx Research (Canada)), Girolama Alessandra Marfia(NeuroRx Research (Canada)), Clyde Markowitz(NeuroRx Research (Canada)), Vasileios Mastorodimos(NeuroRx Research (Canada)), Klotild Mátyás(NeuroRx Research (Canada)), José Meca-Lallana(NeuroRx Research (Canada)), Juan Antonio García Merino(NeuroRx Research (Canada)), Ioan Gheorghe Mihetiu(NeuroRx Research (Canada)), Ivan Milanov(NeuroRx Research (Canada)), Aaron E. Miller(NeuroRx Research (Canada)), Andrejs Millers(NeuroRx Research (Canada)), Massimiliano Mirabella(NeuroRx Research (Canada)), Masanori Mizuno(NeuroRx Research (Canada)), Xavier Montalbán(NeuroRx Research (Canada)), L. Montoya(NeuroRx Research (Canada)), Masahiro Mori(NeuroRx Research (Canada)), Stefanie Mueller(NeuroRx Research (Canada)), Jin Nakahara(NeuroRx Research (Canada)), Yuji Nakatsuji(NeuroRx Research (Canada)), Scott D. Newsome(NeuroRx Research (Canada)), Richard Nicholas(NeuroRx Research (Canada)), A. Scott Nielsen(NeuroRx Research (Canada)), Esmaeil Nikfekr(NeuroRx Research (Canada)), Ugo Nocentini(NeuroRx Research (Canada)), Chiyoko Nohara(NeuroRx Research (Canada)), Kyoichi Nomura(NeuroRx Research (Canada)), Odinak Mm(NeuroRx Research (Canada)), Tomas Olsson(NeuroRx Research (Canada)), Bob W. van Oosten(NeuroRx Research (Canada)), Celia Oreja‐Guevara(NeuroRx Research (Canada)), Patrick Oschmann(Inserm), James Overell(NeuroRx Research (Canada)), Andrew R. Pachner(NeuroRx Research (Canada)), Gyula Pánczél(NeuroRx Research (Canada)), Massimo Pandolfo(NeuroRx Research (Canada)), Caroline Papeix(NeuroRx Research (Canada)), Liliana Patrucco(NeuroRx Research (Canada)), Jean Pelletier(Centre de Résonance Magnétique Biologique et Médicale), Raúl Piedrabuena(NeuroRx Research (Canada)), Misha Pless(NeuroRx Research (Canada)), Udo Polzer(NeuroRx Research (Canada)), Krisztián Pozsegovits(NeuroRx Research (Canada)), Daiva Rastenytė(NeuroRx Research (Canada)), Sebastian Rauer(NeuroRx Research (Canada)), Gerd Reifschneider(NeuroRx Research (Canada)), Roberto Rey(NeuroRx Research (Canada)), Syed Rizvi(NeuroRx Research (Canada)), Derrick Robertson(NeuroRx Research (Canada)), Jose Martinez Rodriguez(NeuroRx Research (Canada)), David Rog(NeuroRx Research (Canada)), Homayoun Roshanisefat(NeuroRx Research (Canada)), Vernon Rowe(NeuroRx Research (Canada)), Csilla Rózsa(NeuroRx Research (Canada)), Susan Rubin(NeuroRx Research (Canada)), Stanisław Rusek(NeuroRx Research (Canada)), Francesco Saccà(NeuroRx Research (Canada)), Takahiko Saida(NeuroRx Research (Canada)), António Vasco Salgado(NeuroRx Research (Canada)), Victoria Eugenia Fernández Sánchez(NeuroRx Research (Canada)), Kalina Sanders(NeuroRx Research (Canada)), Mária Sátori(NeuroRx Research (Canada)), Д В Сазонов(NeuroRx Research (Canada)), Elio Scarpini(NeuroRx Research (Canada)), Eugen Schlegel(NeuroRx Research (Canada)), Myriam Schluep(NeuroRx Research (Canada)), Stephan Schmidt(NeuroRx Research (Canada)), E. Scholz(NeuroRx Research (Canada)), Hans M. Schrijver(Inserm), Matthias Schwab(NeuroRx Research (Canada)), Raymond Schwartz(NeuroRx Research (Canada)), James A. Scott(NeuroRx Research (Canada)), Krzysztof Selmaj(NeuroRx Research (Canada)), S. James Shafer(NeuroRx Research (Canada)), Basil Sharrack(NeuroRx Research (Canada)), И А Щукин(NeuroRx Research (Canada)), Yuko Shimizu(NeuroRx Research (Canada)), Penko Shotekov(NeuroRx Research (Canada)), Arno Siever(Novartis (Switzerland)), Karl-Otto Sigel(NeuroRx Research (Canada)), Scott Silliman(NeuroRx Research (Canada)), Magdolna Simó(NeuroRx Research (Canada)), Mihaela Simu(NeuroRx Research (Canada)), Vladimiro Sinay(NeuroRx Research (Canada)), Antonio Escartin Siquier(NeuroRx Research (Canada)), Aksel Sıva(NeuroRx Research (Canada)), Ondřej Škoda(NeuroRx Research (Canada)), Andrew Solomon(NeuroRx Research (Canada)), Martin Stangel(NeuroRx Research (Canada)), Dusan Stefoski(NeuroRx Research (Canada)), Brian Steingo(NeuroRx Research (Canada)), I D Stolyarov(NeuroRx Research (Canada)), Pavel Štourač(NeuroRx Research (Canada)), Katrin Straßburger-Krogias(NeuroRx Research (Canada)), Erik Strauss(Novartis (Switzerland)), Olaf Stüve(NeuroRx Research (Canada)), Ivaylo Tarnev(NeuroRx Research (Canada)), Antonios Tavernarakis(NeuroRx Research (Canada)), Cristina Ramo‐Tello(NeuroRx Research (Canada)), Murat Terzi(NeuroRx Research (Canada)), Veronika Tichá(NeuroRx Research (Canada)), Marina Ticmeanu(NeuroRx Research (Canada)), Klaus Tiel‐Wilck(NeuroRx Research (Canada)), Toomas Toomsoo(NeuroRx Research (Canada)), Niall Tubridy(NeuroRx Research (Canada)), Mark Tullman(NeuroRx Research (Canada)), Hayrettin Tumani(NeuroRx Research (Canada)), Peter Turčáni(NeuroRx Research (Canada)), Ben Turner(NeuroRx Research (Canada)), Antonio Uccelli(NeuroRx Research (Canada)), Francisco Javier Olascoaga Urtaza(NeuroRx Research (Canada)), Marta Vachová(NeuroRx Research (Canada)), Attila Valikovics(NeuroRx Research (Canada)), Silke Walter(NeuroRx Research (Canada)), Bart Van Wijmeersch(NeuroRx Research (Canada)), Ludo Vanopdenbosch(NeuroRx Research (Canada)), Joerg R. Weber(NeuroRx Research (Canada)), Sara Weiss(NeuroRx Research (Canada)), Robert Weissert(Cleveland Clinic), Patrick Vermersch(Inserm), T. Eoin West(NeuroRx Research (Canada)), Heinz Wiendl(NeuroRx Research (Canada)), Sandrine Wiertlewski(NeuroRx Research (Canada)), Brigitte Wildemann(NeuroRx Research (Canada)), Barbara Willekens(NeuroRx Research (Canada)), Leo H. Visser(NeuroRx Research (Canada)), Galina Vorobeychik(NeuroRx Research (Canada)), Xianhao Xu(NeuroRx Research (Canada)), Takashi Yamamura(NeuroRx Research (Canada)), Yi Yang(NeuroRx Research (Canada)), Sergio Martínez‐Yélamos(NeuroRx Research (Canada)), Michael Yeung(NeuroRx Research (Canada)), Alan Zacharias(NeuroRx Research (Canada)), Marvin V. Zelkowitz(NeuroRx Research (Canada)), Uwe K. Zettl(NeuroRx Research (Canada)), Meini Zhang(NeuroRx Research (Canada)), Hongyu Zhou(NeuroRx Research (Canada)), Ulf Zieman(NeuroRx Research (Canada)), Tjalf Ziemssen(NeuroRx Research (Canada))
The Lancet
March 1, 2018
Cited by 919

Abstract


Related Papers

No related papers found

Powered by citation graph analysis